Etelae-Pohjanmaan hyvinvointialue
- Address
- Hanneksenrinne 7, 60220 Seinäjoki, Finland
Etelae-Pohjanmaan Hyvinvointialue - Prostate Cancer Research Center
Etelae-Pohjanmaan hyvinvointialue is a specialized clinical research center with dedicated expertise in advanced prostate cancer therapeutics. The center focuses on evaluating innovative treatment strategies for patients with progressive and metastatic castrate-resistant prostate cancer (mCRPC), conducting pivotal trials that compare novel radiopharmaceuticals, hormonal therapies, and combination treatment approaches to optimize patient outcomes and survival.
- Radiopharmaceutical therapy with radium-223 dichloride for bone-metastatic prostate cancer
- Hormonal therapy combinations including enzalutamide and leuprolide for high-risk nonmetastatic disease
- Statin intervention studies during androgen deprivation therapy to delay castration resistance
The research program emphasizes overall survival outcomes and disease progression management across the prostate cancer continuum, from high-risk localized disease following definitive therapy to advanced metastatic states. The center's trials investigate critical therapeutic questions including the role of androgen deprivation therapy (ADT) optimization, the timing of second-line hormonal agents, and novel approaches to preventing or delaying the development of treatment resistance in progressive prostate cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pirkanmaan hyvinvointialue1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Etelae-Pohjanmaan hyvinvointialue
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Enzalutamide and Leuprorelin Acetate in High-Risk Nonmetastatic Prostate Cancer Post-Definitive Therapy | Medivation Inc. | Phase III | Not Recruiting | Aug 2015 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Enzalutamide | 2 | Unknown | 2015-08-19 | 2020-08-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.